As of Feb 27
| +0.02 / +1.57%|
The 1 analysts offering 12-month price forecasts for CAS Medical Systems Inc have a median target of 3.50, with a high estimate of 3.50 and a low estimate of 3.50. The median estimate represents a +171.32% increase from the last price of 1.29.
The current consensus among 1 polled investment analysts is to Buy stock in CAS Medical Systems Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.